Teslas Full SelfDriving Supervised Debuts in China Amid Intensifying Competition from Local EV Rivals CXMT Reports Strong Growth Figures Amid IPO Ambitions Prediction Markets Surge Among Young Male Traders A Demographic Shift in Speculative Finance Kevin Warsh Takes Helm as Fed Chair Pledges ReformOriented Approach Global Stock Markets Reach Record Highs as Oil Prices Slide on USIran Peace Hopes US Stock Futures and Bond Yields Dip on Reports of Putins Nuclear Doctrine Update ONEW Q1 2026 Earnings Deep EPS Miss Masks Underlying Optimism as Shares Rally 4 BHFAO Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement STOK Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline IHG Q4 2025 Earnings EPS Misses Estimates Amid Modest Stock Uptick VSAT Q1 2026 Earnings Strong EPS Surprise Drives Shares Higher AFLAC Q1 2026 Earnings EPS Misses Estimates Amid Operating Challenges Jaguar Health JAGX Surges 687 as Shares Test Critical Resistance at 327 Erasca Inc ERAS Slides 315 as Biotech Sector Faces Pressure Key Levels to Watch Hudson Technologies HDSN Rallies 198 Testing Key Resistance at 542 Stifel Financial 520 Senior Notes SFB Slide Slightly as FixedIncome Market Holds Steady Kentucky First Federal Bancorp KFFB Retreats 215 Key Support Levels in Focus TBRG Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Despite Disappointing Quarter SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Solid Biosciences Inc SLDB Q1 2026 Earnings Wider Loss Reported as Pipeline Investment Continues APWC Q3 1997 Earnings EPS Misses Estimates Amid Challenging Conditions American Vanguard Corporation AVD Q3 2025 Earnings Deep EPS Miss and Steep Stock Decline Highlight Operational Headwinds Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss and Pipeline Progress Support Positive Market Reaction Barclays Increases Energy Transfer Price Target Citing Undervaluation Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Iovance Biotherapeutics IOVA Hovers Near Key Support as Stock Edges Lower